Portal de Periódicos da CAPES

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation

2023; Lippincott Williams & Wilkins; Volume: 149; Issue: 10 Linguagem: Inglês

10.1161/circulationaha.123.067312

1524-4539

Samir R. Kapadia, Amar Krishnaswamy, Brian Whisenant, Srinivasa Potluri, Vijay Iyer, Joseph Aragon, Philip A. Gideon, Justin A. Strote, Robert A. Leonardi, Himanshu Agarwal, Germán Larrain, Carlos E. Sanchez, Sidakpal Panaich, James E. Harvey, Torsten Vahl, Venu Menon, Kathy Wolski, Qiuqing Wang, Martin B. Leon,

Cardiac Imaging and Diagnostics

Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased risk of bleeding and stroke. While left atrial appendage occlusion (LAAO) is approved as an alternative to anticoagulants for stroke prevention in patients with AF, placement of these devices in patients with severe aortic stenosis, or when performed at the same time as TAVR, has not been extensively studied.